Correlation Between Angion Biomedica and Pyxis Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Angion Biomedica and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Angion Biomedica and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Angion Biomedica Corp and Pyxis Oncology, you can compare the effects of market volatilities on Angion Biomedica and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Angion Biomedica with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Angion Biomedica and Pyxis Oncology.

Diversification Opportunities for Angion Biomedica and Pyxis Oncology

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Angion and Pyxis is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Angion Biomedica Corp and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Angion Biomedica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Angion Biomedica Corp are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Angion Biomedica i.e., Angion Biomedica and Pyxis Oncology go up and down completely randomly.

Pair Corralation between Angion Biomedica and Pyxis Oncology

If you would invest  1,000.00  in Angion Biomedica Corp on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Angion Biomedica Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Angion Biomedica Corp  vs.  Pyxis Oncology

 Performance 
       Timeline  
Angion Biomedica Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Angion Biomedica Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Angion Biomedica is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Pyxis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Angion Biomedica and Pyxis Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Angion Biomedica and Pyxis Oncology

The main advantage of trading using opposite Angion Biomedica and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Angion Biomedica position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.
The idea behind Angion Biomedica Corp and Pyxis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine